ResearcherXinjiang Medical UniversityNo recent work listed
Chao Yi
Matched on ORCID iD 0000-0002-8559-0104; OpenAlex author ID A5102910984. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 5
2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: 1 paper · 2019: none · 2020: none · 2021: 1 paper
Papers 3
- Desmoglein 3 contributes to tumorigenicity of pancreatic ductal adenocarcinoma through activating Src-FAK signaling. Last author DOI 10.1080/19768354.2021.1943707↗
- Expression of Smo in pancreatic cancer CD44+CD24+cells and construction of a lentiviral expression vector to silence Smo. First author DOI 10.3892/ol.2018.9315↗
- Concomitant targeting of multiple key transcription factors effectively disrupts cancer stem cells enriched in side population of human pancreatic cancer cells. Co-author DOI 10.1371/journal.pone.0073942↗
Closest collaborators
The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yimamumaimaitijiang Abula · 1 shared paper, 2021 · strength 0.19
- Xiyan Wang · 2 shared papers, 2013–2018 · strength 0.17
- Paper Expression of Smo in pancreatic cancer CD44+CD24+cells and construction of a lentiviral expression vector to silence Sm… DOI 10.3892/ol.2018.9315↗
- Paper Concomitant targeting of multiple key transcription factors effectively disrupts cancer stem cells enriched in side pop… DOI 10.1371/journal.pone.0073942↗
- Cong Peng · 1 shared paper, 2018 · strength 0.14
- Dong Yan · 1 shared paper, 2013 · strength 0.03
- Hai Wang · 1 shared paper, 2013 · strength 0.03
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.